The Role of KCNMB1 and the Large Conductance Potassium (BK) Channel in Myofibroblast Differentiation and Pulmonary Fibrosis
The Role of KCNMB1 and the Large Conductance Potassium (BK) Channel in Myofibroblast Differentiation and Pulmonary Fibrosis
批准号:
10617785
负责人:
STEVEN K HUANG
金额:
$51.03万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-04-01 至 2025-05-31
关键词:
ActinsAnimal ModelBiologyBladderBlood VesselsCalcium ChannelCalcium SignalingCicatrixCodeContractsCytoplasmDNA MethylationDataDevelopmentDiseaseDisease ProgressionDisease modelDrug TargetingEpigenetic ProcessExhibitsExtracellular MatrixFibroblastsFibrosisFutureGene ExpressionGenesGenomeGoalsGrantIon ChannelLaboratoriesLiteratureLungLung diseasesMediatorMethylationMissionMusMyofibroblastPathogenesisPathogenicityPathway interactionsPatientsPlayPotassiumPotassium ChannelPublic HealthPublicationsPublishingPulmonary FibrosisPulmonary InflammationRelaxationRoleSignal TransductionSmooth MuscleStimulusTestingTherapeuticTimeUnited States National Institutes of HealthUp-RegulationWorkcell typeclinical heterogeneityeffective therapyfibrogenesisidiopathic pulmonary fibrosisin vivointerestlarge-conductance calcium-activated potassium channelslung injurynovelnovel therapeutic interventionresponsesuccesstargeted treatmentwound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Despite major advances in the understanding of the pathogenesis of pulmonary fibrosis, many of the therapies
that target the most well-studied genes and pathways have not achieved universal success in reversing or
even halting disease progression. This, along with the clinical heterogeneity of patients with idiopathic
pulmonary fibrosis (IPF), suggest that consideration of other genes in models of disease pathogenesis may be
useful. Fibroblasts from patients with IPF differ in the expression of many genes compared to normal
fibroblasts, and this laboratory has had a longstanding interest in identifying epigenetic changes that account
for these differences. KCNMB1 codes for the beta subunit of the large conductance (BK, Maxi-K, KCa1.1)
potassium channel and was identified in our previous microarray study as the top differentially methylated gene
in IPF fibroblasts. BK channels modulate potassium current and are well known to be important in vascular
tone and smooth muscle biology, but its importance in fibrosis has never been examined. We recently showed
in a publication that 1) KCNMB1 expression is increased in fibroblasts from IPF patients, 2) KCNMB1
contributes to increased BK channel activity, and 3) increased function of BK channels promote myofibroblast
differentiation, a hallmark of IPF. How it does so and whether this is sufficient to promote or worsen pulmonary
fibrosis in vivo is unknown. The objectives of this grant are to determine the mechanism of how BK channels
contribute to myofibroblast differentiation and establish the importance of BK channels to animal models of
pulmonary fibrosis. Our central hypothesis is that the epigenetic upregulation of KCNMB1 and increased BK
channel activity in IPF fibroblasts contribute to pulmonary fibrosis by promoting calcium signaling in fibroblasts,
which lead to myofibroblast differentiation. The First Aim is to establish the importance of BK channels to the
development of pulmonary fibrosis in vivo, and localize its pathogenic actions to lung fibroblasts. The Second
Aim is to delineate the mechanism by which BK channels contribute to myofibroblast differentiation, with the
hypothesis that BK channels promote intracellular calcium signaling, which is necessary for differentiation into
myofibroblasts. The Third Aim is to determine how expression of KCNMB1 is regulated in lung fibroblasts and
how profibrotic stimuli modulates opening and closing of BK channels. This proposal is significant because it
establishes BK channels as a novel, but important driver in the pathogenesis of pulmonary fibrosis.
Accomplishing these aims will also identify a mechanism and role for BK channels in the differentiation of
myofibroblasts that has never been previously described. Ultimately, these studies will serve to identify new
targets for future IPF therapeutics.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
KLF4 is a therapeutically tractable brake on fibroblast activation that promotes resolution of pulmonary fibrosis.
KLF4是一种可在成纤维细胞激活上进行治疗的制动器,可促进肺纤维化的分辨率。
DOI:
10.1172/jci.insight.160688
发表时间:
2022-08-22
期刊:
JCI INSIGHT
影响因子:
8
作者:
[Penke, Loka R., Speth, Jennifer M., Huang, Steven K., Fortier, Sean M., Baas, Jared, Peters-Golden, Marc]
通讯作者:
Peters-Golden, Marc
MAP kinase phosphatase-1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution.
肺肌成纤维细胞内 p38α 的 MAP 激酶磷酸酶 1 抑制对于自发性纤维化消退至关重要。
DOI:
10.1172/jci172826
发表时间:
2024
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
[Fortier,SeanM, Walker,NatalieM, Penke,LokaR, Baas,JaredD, Shen,Qinxue, Speth,JenniferM, Huang,StevenK, Zemans,RachelL, Bennett,AntonM, Peters-Golden,Marc]
通讯作者:
Peters-Golden,Marc
DOI:
10.1016/j.ajpath.2021.10.011
发表时间:
2021-11
期刊:
The American journal of pathology
影响因子:
--
作者:
[G. Qian;O. Adeyanju;C. Sunil;Steven K. Huang;Shi-You Chen;T. Tucker;S. Idell;Xia Guo]
通讯作者:
G. Qian;O. Adeyanju;C. Sunil;Steven K. Huang;Shi-You Chen;T. Tucker;S. Idell;Xia Guo
Outstaying their Welcome: The Persistent Myofibroblast in IPF.
不受欢迎:IPF 中的持久性肌成纤维细胞。
DOI:
--
发表时间:
2014
期刊:
Austin journal of pulmonary and respiratory medicine
影响因子:
--
作者:
[Huang,StevenK, Horowitz,JeffreyC]
通讯作者:
Horowitz,JeffreyC
DOI:
10.1038/s41598-022-07044-3
发表时间:
2022-02-23
期刊:
Scientific reports
影响因子:
4.6
作者:
[Guo X, Sunil C, Adeyanju O, Parker A, Huang S, Ikebe M, Tucker TA, Idell S, Qian G]
通讯作者:
Qian G
共 11 条
Heterogeneity and Regulation of the DNA Methylome in IPF Mesenchymal Cells
-
批准号:10584069
-
项目类别:
-
资助金额:$77.5万
-
财政年份:2023
-
负责人:STEVEN K HUANG
-
依托单位:
CDKN2B as a Novel Epigenetically Regulated Gene in Idiopathic Pulmonary Fibrosis
-
批准号:9247799
-
项目类别:
-
资助金额:$37.8万
-
财政年份:2015
-
负责人:STEVEN K HUANG
-
依托单位:
The Role of KCNMB1 and the Large Conductance Potassium (BK) Channel in Myofibroblast Differentiation and Pulmonary Fibrosis
-
批准号:10408754
-
项目类别:
-
资助金额:$51.03万
-
财政年份:2015
-
负责人:STEVEN K HUANG
-
依托单位:
The Role of KCNMB1 and the Large Conductance Potassium (BK) Channel in Myofibroblast Differentiation and Pulmonary Fibrosis
-
批准号:10171415
-
项目类别:
-
资助金额:$51.03万
-
财政年份:2015
-
负责人:STEVEN K HUANG
-
依托单位:
CDKN2B as a Novel Epigenetically Regulated Gene in Idiopathic Pulmonary Fibrosis
-
批准号:9032525
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2015
-
负责人:STEVEN K HUANG
-
依托单位:
The Altered DNA Methylome as a Determinant of Variable Disease Progression in IPF
-
批准号:8903517
-
项目类别:
-
资助金额:$43.62万
-
财政年份:2014
-
负责人:STEVEN K HUANG
-
依托单位:
Epigenetic Regulation of the E Prostanoid 2 Receptor Gene in Lung Fibroblasts
-
批准号:7798194
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2009
-
负责人:STEVEN K HUANG
-
依托单位:
Epigenetic Regulation of the E Prostanoid 2 Receptor Gene in Lung Fibroblasts
-
批准号:8241049
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2009
-
负责人:STEVEN K HUANG
-
依托单位:
Epigenetic Regulation of the E Prostanoid 2 Receptor Gene in Lung Fibroblasts
-
批准号:8054188
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2009
-
负责人:STEVEN K HUANG
-
依托单位:
Epigenetic Regulation of the E Prostanoid 2 Receptor Gene in Lung Fibroblasts
-
批准号:8449679
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2009
-
负责人:STEVEN K HUANG
-
依托单位:
Epigenetic Regulation of the E Prostanoid 2 Receptor Gene in Lung Fibroblasts
-
批准号:7570858
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2009
-
负责人:STEVEN K HUANG
-
依托单位:
海外基金